Tech Company Financing Transactions

NanoViricides Funding Round

NanoViricides closed a $4.3 million funding round on 10/5/2009. Investors included private investors.

Transaction Overview

Company Name
Announced On
10/5/2009
Transaction Type
Venture Equity
Amount
$4,300,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Nanotechnology
Mailing Address
1 Controls Dr.
Shelton, CT 06484
USA
Email Address
Overview
NanoViricides (OTC BB: NNVC.OB) has assembled a world class team to lead us to success. We have brought together highly experienced individuals with strong expertise in their respective areas.
Profile
NanoViricides LinkedIn Company Profile
Social Media
NanoViricides Company Twitter Account
Company News
NanoViricides News
Facebook
NanoViricides on Facebook
YouTube
NanoViricides on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Anil Diwan
  Anil Diwan LinkedIn Profile  Anil Diwan Twitter Account  Anil Diwan News  Anil Diwan on Facebook
Chief Financial Officer
Meeta Vyas
  Meeta Vyas LinkedIn Profile  Meeta Vyas Twitter Account  Meeta Vyas News  Meeta Vyas on Facebook
Chief Scientific Officer
Randall Barton
  Randall Barton LinkedIn Profile  Randall Barton Twitter Account  Randall Barton News  Randall Barton on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/4/2009: Direct Flow Medical venture capital transaction
Next: 10/5/2009: QSecure venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary